CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Forest Laboratories, LLC v. Accord Healthcare, Inc.

1:16-cv-00375

Overview

Case Number 1:16-cv-00375
Filing Date 2016-05-20
Status Terminated
Termination Date 2016-07-27
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Forest Laboratories, LLC Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Intas Pharmaceuticals Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Plaintiff

Allergan USA, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Accord Healthcare, Inc. Operating Company

Represented By

2 Attorneys Listed

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Counter Defendant

Adamas Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Forest Laboratories Holdings, Ltd. NPE (Patent Assertion Entity)

Represented By

2 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8039009
Modified release formulations of memantine oral dosage forms
Filed: 2005-06-16
Issued: 2011-10-18
Active (2.3 yrs remaining) +1377d PTA
Expires: 2029-03-24
US8058291
Methods and compositions for the treatment of CNS-related conditions
Filed: 2006-04-06
Issued: 2011-11-15
Active (3.0 yrs remaining) +1339d PTA
Expires: 2029-12-05
US8168209
Method and composition for administering an NMDA receptor antagonist to a subject
Filed: 2009-07-30
Issued: 2012-05-01
Expired (Term Ended)
Expires: 2026-07-18
US8173708
Method and composition for administering an NMDA receptor antagonist to a subject
Filed: 2010-04-09
Issued: 2012-05-08
Expired (Term Ended)
Expires: 2025-12-02
US8283379
Methods and compositions for the treatment of CNS-related conditions
Filed: 2010-04-09
Issued: 2012-10-09
Expired (Term Ended)
Expires: 2026-05-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1377 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(18 total)
Pleading / Complaint

COMPLAINT filed against Accord Healthcare, Inc., Intas Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1934805.) - filed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Adamas Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-L, # 2 Civil Cover Sheet)(sar) (Entered: 05/20/2016)

Entry #1 • 2016-05-20
1
Pleading / Complaint

COMPLAINT filed against Accord Healthcare, Inc., Intas Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1934805.) - filed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Adamas Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-L, # 2 Civil Cover Sheet)(sar) (Entered: 05/20/2016)

Entry #1 • 2016-05-20
2
Pleading / Complaint

COMPLAINT filed against Accord Healthcare, Inc., Intas Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1934805.) - filed by Forest Laboratories, LLC, Forest Laboratories Holdings, Ltd., Allergan USA, Inc., Adamas Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A-L, # 2 Civil Cover Sheet)(sar) (Entered: 05/20/2016)

Entry #1 • 2016-05-20
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) (Entered: 05/20/2016)

Entry #2 • 2016-05-20
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/6/2016. Date of Expiration of Patent: 8,039,009 - September 24, 2029, 8,329,752 - May 22, 2026 8,058,291 - December 5, 2029 8,338,485 - November 22, 2025 8,168,209 - May 22, 2026 8,338,486 - November 22, 2025 8,173,708 - May 22, 2026 8,362,085 - May 22, 2026 8,283,379 - May 22, 2026 8,580,858 - November 22, 2025 8,293,794 - November 22, 2025 8,598,233 - May 22, 2026.Thirty Month Stay Deadline: 11/6/2018. (sar) (Entered: 05/20/2016)

Entry #3 • 2016-05-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc